As the end of the Transition Period nears, the Department of Health and Social Care (DHSC) has issued advice on how to supply Northern Ireland with medicines under new legal arrangements.
Under the Northern Ireland protocol, the country will be obliged to align with the EU for the time being, complicating routes of supply.
The new guidance clarifies the situation for existing medicines. DHSC says:
“Goods placed on the market in the European Union or the United Kingdom before the end of the transition period may continue to circulate between these two markets from 1 January 2021.
“This is stated in Article 41 of the EU Withdrawal Agreement.”
The guidance explains that companies or wholesalers in the UK will be legally able to supply wholesalers in Northern Ireland if products were available before 11pm on 31st December 2020.
The guidance also confirms the administrative requirements underpinning this approach, in which:
“The wholesale dealer or manufacturer in Great Britain will be responsible for confirming that the person to be supplied in Northern Ireland is authorised to receive the product. This must be prior to agreeing to supply the products.”
Refer to the guidance for more information.